These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37478462)

  • 21. Use of Physiologically Based Kinetic Modeling-Based Reverse Dosimetry to Predict in Vivo Toxicity from in Vitro Data.
    Louisse J; Beekmann K; Rietjens IM
    Chem Res Toxicol; 2017 Jan; 30(1):114-125. PubMed ID: 27768849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting the in vivo developmental toxicity of benzo[a]pyrene (BaP) in rats by an in vitro-in silico approach.
    Wang D; Rietdijk MH; Kamelia L; Boogaard PJ; Rietjens IMCM
    Arch Toxicol; 2021 Oct; 95(10):3323-3340. PubMed ID: 34432120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new approach methodology (NAM) for the prediction of (nor)ibogaine-induced cardiotoxicity in humans.
    Shi M; Wesseling S; Bouwmeester H; Rietjens IMCM
    ALTEX; 2021; 38(4):636-652. PubMed ID: 34271588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making.
    Paini A; Leonard JA; Joossens E; Bessems JGM; Desalegn A; Dorne JL; Gosling JP; Heringa MB; Klaric M; Kliment T; Kramer NI; Loizou G; Louisse J; Lumen A; Madden JC; Patterson EA; Proença S; Punt A; Setzer RW; Suciu N; Troutman J; Yoon M; Worth A; Tan YM
    Comput Toxicol; 2019 Feb; 9():61-72. PubMed ID: 31008414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of in vivo genotoxicity of lasiocarpine and riddelliine in rat liver using a combined in vitro-physiologically based kinetic modelling-facilitated reverse dosimetry approach.
    Chen L; Peijnenburg A; de Haan L; Rietjens IMCM
    Arch Toxicol; 2019 Aug; 93(8):2385-2395. PubMed ID: 31289892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral Chronic Toxicity of the Safe Tetrodotoxin Dose Proposed by the European Food Safety Authority and Its Additive Effect with Saxitoxin.
    Boente-Juncal A; Otero P; Rodríguez I; Camiña M; Rodriguez-Vieytes M; Vale C; Botana LM
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32397553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive performance of next generation human physiologically based kinetic (PBK) models based on in vitro and in silico input data.
    Punt A; Louisse J; Beekmann K; Pinckaers N; Fabian E; Van Ravenzwaay B; Carmichael PL; Sorrell I; Moxon TE
    ALTEX; 2022; 39(2):221–234. PubMed ID: 35064272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards a generic physiologically based kinetic model to predict in vivo uterotrophic responses in rats by reverse dosimetry of in vitro estrogenicity data.
    Zhang M; van Ravenzwaay B; Fabian E; Rietjens IMCM; Louisse J
    Arch Toxicol; 2018 Mar; 92(3):1075-1088. PubMed ID: 29234833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of toxicokinetics and alternative testing strategies in pyrrolizidine alkaloid toxicity and risk assessment; state-of-the-art and future perspectives.
    Ning J; Chen L; Rietjens IMCM
    Food Chem Toxicol; 2019 Sep; 131():110572. PubMed ID: 31185270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.
    Chou WC; Lin Z
    Environ Int; 2019 Aug; 129():408-422. PubMed ID: 31152982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of in vitro data in physiologically-based kinetic models for quantitative in vitro-in vivo extrapolation: A case-study for baclofen.
    Kasteel EEJ; Lautz LS; Culot M; Kramer NI; Zwartsen A
    Toxicol In Vitro; 2021 Oct; 76():105223. PubMed ID: 34293430
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Algharably EA; Di Consiglio E; Testai E; Pistollato F; Mielke H; Gundert-Remy U
    Front Toxicol; 2022; 4():885843. PubMed ID: 35924078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applicability of generic PBK modelling in chemical hazard assessment: A case study with IndusChemFate.
    Fragki S; Piersma AH; Westerhout J; Kienhuis A; Kramer NI; Zeilmaker MJ
    Regul Toxicol Pharmacol; 2022 Dec; 136():105267. PubMed ID: 36367522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of
    Algharably EA; Di Consiglio E; Testai E; Pistollato F; Bal-Price A; Najjar A; Kreutz R; Gundert-Remy U
    Front Pharmacol; 2023; 14():1136174. PubMed ID: 36959852
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro to in vivo extrapolation of effective dosimetry in developmental toxicity testing: Application of a generic PBK modelling approach.
    Fragki S; Piersma AH; Rorije E; Zeilmaker MJ
    Toxicol Appl Pharmacol; 2017 Oct; 332():109-120. PubMed ID: 28760446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inter-individual variation in chlorpyrifos toxicokinetics characterized by physiologically based kinetic (PBK) and Monte Carlo simulation comparing human liver microsome and Supersome
    Zhao S; Wesseling S; Rietjens IMCM; Strikwold M
    Arch Toxicol; 2022 May; 96(5):1387-1409. PubMed ID: 35294598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of an in vitro-in silico testing strategy to predict inter-species and inter-ethnic human differences in liver toxicity of the pyrrolizidine alkaloids lasiocarpine and riddelliine.
    Ning J; Chen L; Strikwold M; Louisse J; Wesseling S; Rietjens IMCM
    Arch Toxicol; 2019 Mar; 93(3):801-818. PubMed ID: 30661089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of long-term low dose saxitoxin exposure on nerve damage in mice.
    Sun Q; Chen X; Liu W; Li S; Zhou Y; Yang X; Liu J
    Aging (Albany NY); 2021 Jul; 13(13):17211-17226. PubMed ID: 34197336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Acute Toxicity of Tetrodotoxin and Tetrodotoxin⁻Saxitoxin Mixtures to Mice by Various Routes of Administration.
    Finch SC; Boundy MJ; Harwood DT
    Toxins (Basel); 2018 Oct; 10(11):. PubMed ID: 30360529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiologically based kinetic modeling of hesperidin metabolism and its use to predict in vivo effective doses in humans.
    Boonpawa R; Spenkelink A; Punt A; Rietjens IMCM
    Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28218440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.